A platform for locoregional T-cell immunotherapy to control HNSCC recurrence following tumor resection

Surgical resection of head and neck squamous-cell carcinoma (HNSCC) is associated with high rates of local and distant recurrence, partially mitigated by adjuvant therapy. A pre-existing immune response in the patient’s tumor is associated with better outcomes following treatment with conventional t...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharon, Shay, Baird, Jason R., Bambina, Shelly, Kramer, Gwen, Blair, Tiffany C., Jensen, Shawn M., Leidner, Rom S., Bell, R. Bryan, Casap, Nardy, Crittenden, Marka R., Gough, Michael J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238246/
https://www.ncbi.nlm.nih.gov/pubmed/34194619
http://dx.doi.org/10.18632/oncotarget.27982

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238246/
https://www.ncbi.nlm.nih.gov/pubmed/34194619
http://dx.doi.org/10.18632/oncotarget.27982

Ejemplares similares